Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.
The target company is a drug discovery contract research organisation.
The acquirer company expects the acquisition to help grow its pipeline.
China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province.
The purchase consideration for the transaction is expected to be CNY286.2m ($42.05m).